SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-016160
Filing Date
2020-07-31
Accepted
2020-07-31 16:02:38
Documents
1
Period of Report
2020-09-10
Effectiveness Date
2020-07-31

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A navb20200730_def14a.htm DEF 14A 861848
  Complete submission text file 0001437749-20-016160.txt   863013
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35076 | Film No.: 201065944
SIC: 2835 In Vitro & In Vivo Diagnostic Substances